STOCK TITAN

BIO-key International, Inc. - BKYI STOCK NEWS

Welcome to our dedicated page for BIO-key International news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on BIO-key International stock.

BIO-key International, Inc. (OTCQB: BKYI) is a leading provider of biometric software and hardware authentication solutions for enterprises and consumers alike. Established in 1993, BIO-key has become a trusted name, servicing diverse sectors including Fortune 500 companies, government agencies, healthcare organizations, call centers, schools, retailers, and OEM partners.

BIO-key's product portfolio includes advanced fingerprint biometric identification and identity verification technologies, with popular offerings such as SideSwipe, SidePass, EcoID, and WEB-key. The company's innovative solutions ensure secure and seamless access management, making them a preferred choice for high-security requirements.

In 2016, BIO-key introduced a series of compact fingerprint readers designed for compatibility with Windows Hello. These readers are not only affordable but also easy to install and use, available through major retailers like Amazon, Microsoft, and Dell.com. The company further expanded its consumer reach by launching a series of biometric padlocks at the Consumer Electronics Show in 2017. Their product, TouchLock, received significant acclaim, being featured on over 30 morning television shows.

BIO-key continues to innovate with its 'Biometric of Things' (BoT) initiative, aiming to create a range of biometrically enabled, consumer-friendly products. The company’s focus on the power of a touch drives their mission to enhance security and user experience across various applications.

Financially, BIO-key generates revenue through services, license fees, and other streams. The company remains committed to partnerships and collaborations that expand their market presence and technological capabilities.

One notable partnership is with Humanity International Investments, under the chairmanship of His Highness, Sheikh Marwan bin Mohamed bin Rashid Al Maktoum. This strategic collaboration has led to the launch of the Humanity Protocol, a blockchain-based economic empowerment initiative. The project leverages BIO-key’s biometric palm scan technology to authenticate identities, enabling individuals, particularly in Africa, to claim their digital footprint through Non-Fungible Tokens (NFTs). With over 15,000 palm scans and plans to verify more users, the initiative marks a significant step forward in integrating biometric technology with blockchain for identity verification.

Overall, BIO-key International, Inc. is at the forefront of revolutionizing digital identity and access management, ensuring secure, user-friendly authentication solutions for millions worldwide.

Rhea-AI Summary

BIO-key International (NASDAQ: BKYI) announces the launch of new biometrics hardware solutions, including the Pocket10™ fingerprint scanner and USB-C versions of the SidePass® and SideSwipe® scanners. Designed to meet rising demand from enterprises and government, these devices enhance mobile enrollment and provide secure authentication options. The global biometric market is projected to grow from $22 billion in 2021 to $55 billion by 2027. These innovations strengthen BIO-key's position as a leader in identity and access management solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.42%
Tags
none
-
Rhea-AI Summary

BIO-key International (NASDAQ: BKYI) has partnered with Kristel Communication Ltd., a Kenyan cybersecurity provider, to enhance its distribution of the PortalGuard Identity as a Service (IDaaS) solution in East Africa. Kristel will leverage its reseller network to sell BIO-key’s cloud-based identity management and biometric solutions, catering to commercial and government domains. The partnership aims to capitalize on the rising demand for IDaaS amid the shift to cloud computing and biometric authentication, as predicted by Gartner, which anticipates a 35% growth in the sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.42%
Tags
none
-
Rhea-AI Summary

BIO-key International (Nasdaq: BKYI) has announced a $1.2M, three-year follow-on contract from a Fortune 500 telecommunications client. This order ensures continued support for its enterprise fingerprint biometric authentication platform, safeguarding access for hundreds of thousands of global personnel and supply chain partners. The company's solutions are designed to provide enhanced security and flexibility over traditional multi-factor authentication methods, addressing enterprise needs for secure access management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.28%
Tags
none
Rhea-AI Summary

BIO-key International (BKYI) announced significant growth in product revenue, rising from $257K to nearly $1.4M. The company reported two follow-on orders totaling nearly $500K from a renowned international defense ministry, expanding their biometric authentication solutions. This deployment enhances security for Microsoft applications through biometric single sign-on, demonstrating the efficacy of BIO-key's technology. The ministry's repeated orders reflect their satisfaction with BIO-key's services, indicating a strong partnership and ongoing demand.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.65%
Tags
none
-
Rhea-AI Summary

BIO-key International, Inc. (NASDAQ: BKYI) has announced its PortalGuard IDaaS has been shortlisted as a finalist for SC Media's Trust Awards in the Best Authentication Technology category. This recognition highlights the platform's comprehensive identity and access management capabilities, which include multi-factor authentication, single sign-on, and over 15 authentication methods. With over 20 years of experience, PortalGuard serves various sectors, including healthcare and finance, addressing increasing cybersecurity threats.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.83%
Tags
none
-
Rhea-AI Summary

BIO-key International, Inc. (Nasdaq: BKYI) announced its Q4 and FY 2020 results, reporting a 99% revenue increase in Q4 to $1.1M, and an overall 25% rise to $2.8M for the year. The company completed a $24.8M public offering and ended 2020 with $19.0M in current assets. Notable highlights include the acquisition of PortalGuard, which boosted growth potential and positioned the company for significant expansion, particularly with projected revenues in 2021 between $8M and $12M. Despite a net loss of $1.4M in Q4, improvements in gross margin and operating expenses reflect positive trends.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.5%
Tags
none
Rhea-AI Summary

BIO-key International (BKYI) has announced the shipment of biometric hardware and software to Nigeria, valued at approximately $500K, marking progress in large-scale civil ID and financial inclusion projects. Initially secured in March 2020, these projects faced delays due to COVID-19 and civil unrest. CEO Michael W. DePasquale expressed optimism for increasing deliveries and technology deployments throughout 2021. The company aims to enhance economic empowerment and secure identity management solutions in Nigeria, supporting the government's efforts for financial inclusion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.91%
Tags
none
-
Rhea-AI Summary

BIO-key International (NASDAQ: BKYI) will host a conference call on March 25, 2021, at 10 a.m. ET to discuss its fourth quarter and full FY 2020 results. The results will be announced before the market opens. Participating in the call will be Mike DePasquale (Chairman & CEO), Cecilia Welch (CFO), and Fred Corsentino (Chief Revenue Officer). Investors can join the call by dialing 1-877-418-5460 for U.S. participants or 1-412-717-9594 for international attendees. A live webcast will also be available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.55%
Tags
none
-
Rhea-AI Summary

BIO-key International, Inc. (NASDAQ: BKYI) will host a conference call on March 25, 2020, at 10 a.m. ET to discuss its fourth quarter and full FY 2020 results. The call will feature key executives including Mike DePasquale, Cecilia Welch, and Fred Corsentino. Prior to the call, results will be announced before the market opens. Investors can access the call via dial-in numbers or through a live webcast available for three months post-event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.55%
Tags
none
Rhea-AI Summary

BIO-key International, Inc. (BKYI) announced its participation in the Maxim Group Emerging Growth Virtual Conference on March 18, 2021. The company's Chairman and CEO, Mike DePasquale, will join a 'Security IT' roundtable discussion from 11 AM to 12 PM ET. Attendees can access the conference, featuring various industry discussions and live Q&A sessions, through the registration page. This event showcases BIO-key’s innovative identity and access management solutions powered by biometrics, highlighting its commitment to secure authentication services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.3%
Tags
conferences

FAQ

What is the current stock price of BIO-key International (BKYI)?

The current stock price of BIO-key International (BKYI) is $1.7 as of January 23, 2025.

What is the market cap of BIO-key International (BKYI)?

The market cap of BIO-key International (BKYI) is approximately 6.5M.

What does BIO-key International, Inc. do?

BIO-key is a provider of biometric software and hardware authentication solutions for enterprises and consumers, offering products like fingerprint readers and identity verification technologies.

When was BIO-key International, Inc. established?

BIO-key was established in 1993.

Who are BIO-key's customers?

BIO-key's customers include Fortune 500 companies, government agencies, healthcare organizations, call centers, schools, retailers, and OEM partners.

What are some popular products offered by BIO-key?

Some popular products include SideSwipe, SidePass, EcoID, WEB-key, and biometric padlocks like TouchLock.

What is the 'Biometric of Things' (BoT) initiative?

The BoT initiative aims to create biometrically enabled, consumer-friendly products that enhance security and user experience.

How does BIO-key generate revenue?

BIO-key generates revenue through services, license fees, and other streams.

What is the Humanity Protocol?

The Humanity Protocol is a blockchain-based economic empowerment initiative that uses BIO-key's biometric palm scan technology for identity verification, allowing individuals to claim their digital footprint through NFTs.

Who are BIO-key’s strategic partners?

One notable strategic partner is Humanity International Investments, led by His Highness, Sheikh Marwan bin Mohamed bin Rashid Al Maktoum.

Where can BIO-key products be purchased?

BIO-key products can be purchased through major retailers like Amazon, Microsoft, and Dell.com.

What type of biometric technology does BIO-key specialize in?

BIO-key specializes in fingerprint biometric technology for identification and identity verification.
BIO-key International, Inc.

Nasdaq:BKYI

BKYI Rankings

BKYI Stock Data

6.48M
2.59M
5.58%
9.26%
27.83%
Security & Protection Services
Services-prepackaged Software
Link
United States of America
HOLMDEL